Telmisartan ameliorates experimental autoimmune myocarditis associated with inhibition of inflammation and oxidative stress.

Sukumaran, Vijayakumar

Telmisartan ameliorates experimental autoimmune myocarditis associated with inhibition of inflammation and oxidative stress. [electronic resource] - European journal of pharmacology Feb 2011 - 126-35 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1879-0712

10.1016/j.ejphar.2010.10.081 doi


Angiotensin-Converting Enzyme Inhibitors--pharmacology
Animals
Autoimmune Diseases--drug therapy
Benzimidazoles--pharmacology
Benzoates--pharmacology
Blotting, Western
Cytokines--metabolism
Disease Models, Animal
Endomyocardial Fibrosis--drug therapy
Enzyme-Linked Immunosorbent Assay
Inflammation--drug therapy
Male
Myocarditis--drug therapy
Oxidative Stress--drug effects
Rats
Rats, Inbred Lew
Reverse Transcriptase Polymerase Chain Reaction
Telmisartan